SEI Investments’s enGene Therapeutics ENGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-18,504
Closed -$32K – 3336
2026
Q2
$32K Sell
18,504
-41,532
-69% -$169K ﹤0.01% 3247
2026
Q1
$409K Buy
+60,036
New +$534K ﹤0.01% 2728

Other funds holding ENGN

SEI Investments's ENGN Position: Q3 2026 in Review

SEI Investments sold out of enGene Therapeutics (ENGN) in Q3 2026, closing a stake of 18,504 shares — an estimated $32K sold.

SEI Investments first reported a position in ENGN in Q1 2026 and held it in 2 quarters. The position peaked at $409K in Q1 2026. 60 funds tracked by Wall St. Rank hold ENGN as of Q3 2026.

  • SEI Investments reported no remaining enGene Therapeutics position as of Q3 2026 after selling out during the quarter.
  • SEI Investments sold 18,504 enGene Therapeutics shares in Q3 2026, an estimated $32K.
  • SEI Investments first reported a position in enGene Therapeutics in Q1 2026 and held it in 2 quarters.
  • SEI Investments's enGene Therapeutics position peaked at $409K in Q1 2026.
  • 60 funds tracked by Wall St. Rank held enGene Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.